News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
VINCENT RICHARD G
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Disposed/sold 75,000 options
@ $5.76, valued at
$432k
Disposed/sold 35,120 options
@ $3.33, valued at
$116.9k
Disposed/sold 280,000 options
@ $7.05, valued at
$2M
Disposed/sold 109,579 options
@ $1.94, valued at
$212.6k
Disposed/sold 28,750 options
@ $1.04, valued at
$29.9k
Disposed/sold 210,000 options
@ $0.96, valued at
$201.6k
Granted 75,000 options
@ $0 Granted 35,120 options
@ $0 Granted 280,000 options
@ $0 Granted 109,597 options
@ $0 Granted 28,750 options
@ $0 |
|
07/05/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 7,069 shares
@ $0.36, valued at
$2.5k
|
|
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 210,000 options
@ $0.96, valued at
$201.6k
|
|
01/05/2023 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 4,428 shares
@ $1.02, valued at
$4.5k
|
|
08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2022 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Bought 3 shares
@ $1.45, valued at
$4.4 Bought 356 shares
@ $1.45, valued at
$516.2 Bought 5 shares
@ $1.48, valued at
$7.4 Bought 2,136 shares
@ $1.4899, valued at
$3.2k
Bought 2,500 shares
@ $1.4, valued at
$3.5k
|
|
01/31/2022 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Bought 5,000 shares
@ $1.8, valued at
$9k
Bought 5,000 shares
@ $1.7, valued at
$8.5k
Bought 2,500 shares
@ $1.65, valued at
$4.1k
|
|
01/24/2022 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 109,579 options
@ $1.94, valued at
$212.6k
|
|
01/05/2022 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 29,867 shares
@ $0 |
|
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2020 |
4/A
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 35,120 options to buy
@ $3.33, valued at
$116.9k
|
|
07/31/2020 |
4/A
| VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 75,000 options
@ $5.76, valued at
$432k
|
|
03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2019 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on GTX INC /DE/
Txns:
| Granted 42,628 shares
@ $0 Granted 4,526 shares
@ $0 Granted 1,834 shares
@ $0 Granted 73,385 options
@ $0.81, valued at
$59.4k
Granted 281 warrants
@ $6.13, valued at
$1.7k
|
|
06/11/2019 |
3
| VINCENT RICHARD G (CFO) has filed a Form 3 on GTX INC /DE/ |
10/09/2014 |
4
| VINCENT RICHARD G (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns:
| Granted 50,000 options
@ $4.32, valued at
$216k
|
|
10/31/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/19/2012 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns:
| Disposed/sold 725,000 options to buy
@ $0.16, valued at
$116k
|
|
10/19/2012 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns:
| Disposed/sold 725,000 options to buy
@ $0.16, valued at
$116k
|
|
09/25/2012 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns:
| Granted 3,000,000 options to buy
@ $0.16, valued at
$480k
|
|
03/09/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/09/2010 |
4
| VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns:
| Granted 100,000 options to buy
@ $0.07, valued at
$7k
|
|
02/09/2010 |
3
| VINCENT RICHARD G (CFO) has filed a Form 3 on Sorrento Therapeutics, Inc. |
|
|